VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 75 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,119,313 | +208.8% | 333,723 | +378.9% | 0.00% | – |
| Q2 2023 | $1,657,665 | -85.0% | 69,679 | -83.9% | 0.00% | -100.0% |
| Q1 2023 | $11,018,928 | +12.5% | 433,134 | +29.2% | 0.00% | 0.0% |
| Q4 2022 | $9,794,172 | +189.9% | 335,302 | +103.5% | 0.00% | – |
| Q3 2022 | $3,379,000 | +959.2% | 164,758 | +497.3% | 0.00% | – |
| Q2 2022 | $319,000 | -50.6% | 27,583 | -21.0% | 0.00% | – |
| Q1 2022 | $646,000 | +138.4% | 34,929 | +155.0% | 0.00% | – |
| Q4 2021 | $271,000 | +66.3% | 13,695 | +38.0% | 0.00% | – |
| Q3 2021 | $163,000 | +27.3% | 9,922 | +42.0% | 0.00% | – |
| Q2 2021 | $128,000 | – | 6,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |